Hypoxic lung whiteout: further clearing but more questions from on high.
Swenson
Erik R
ER
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000187:drug effects; D000532:Altitude Sickness / Q000503:physiopathology / Q000517:prevention & control*; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D003907:Dexamethasone / Q000627:therapeutic use*; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000503:physiopathology / Q000517:prevention & control*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D003907:Dexamethasone; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human